Neuroone Medical Technologies (NMTC) EPS (Diluted) Growth (1y) (2011 - 2026)
Neuroone Medical Technologies (NMTC) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 13.96% |
| 10 | Neuroone Medical Technologies | 17.95 Mn | 15.91 Mn | 1.18 Mn | -23.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.63% |
| Mar 31, 2026 | 35.89% |
| Dec 31, 2025 | -149.41% |
| Sep 30, 2025 | 67.79% |
| Jun 30, 2025 | 69.48% |
| Mar 31, 2025 | 33.77% |
| Dec 31, 2024 | 141.47% |
| Sep 30, 2024 | 27.64% |
| Jun 30, 2024 | 48.72% |
| Mar 31, 2024 | 48.66% |
| Dec 31, 2023 | -30.57% |
| Sep 30, 2023 | -101.40% |
| Jun 30, 2023 | -15.79% |
| Mar 31, 2023 | -13.62% |
| Dec 31, 2022 | 41.41% |
| Sep 30, 2022 | 91.98% |
| Jun 30, 2022 | 30.95% |
| Mar 31, 2022 | 11.33% |
| Dec 31, 2021 | 86.05% |
| Sep 30, 2021 | -114.53% |